Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Direct-To-Consumer (DTC) Genetic Testing Industry In 2025?
The direct-to-consumer (dtc) genetic testing market has experienced significant expansion recently. Projections indicate it will grow from $1.84 billion in 2024 to $2.14 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 15.9%. Historically, this expansion is linked to factors such as curiosity about ancestry and heritage, prevalent health and wellness trends, effective marketing and consumer education, increased privacy and control over genetic data, along with greater affordability and accessibility.
The direct-to-consumer (dtc) genetic testing market is anticipated to experience significant expansion over the coming years. This market is projected to reach $3.87 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.0%. Factors contributing to this growth during the forecast period include a broader range of test offerings, greater integration with personalized medicine approaches, partnerships with health and wellness sectors, continuous advancements in genetic research, and supportive government policies and regulations. Key trends expected throughout this period encompass the development of more comprehensive test offerings and panels, initiatives to educate consumers, adherence to regulatory compliance and oversight, increased genomic data research and contributions, along with enhanced affordability and availability.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp
Which Industry Drivers Are Expected To Accelerate The Direct-To-Consumer (DTC) Genetic Testing Market From 2025 To 2029?
The increasing occurrence of illnesses and conditions that can be passed down genetically is projected to boost the expansion of the direct-to-consumer (DTC) genetic testing market. A genetic disorder is defined as a sickness resulting from alterations (mutations) in an individual’s DNA, encompassing single-gene, multifactorial, and chromosomal types. DTC genetic testing enhances understanding of diverse genetic conditions, assisting in health predictions and delivering tailored data concerning an individual’s well-being, susceptibility to illness, and other characteristics. This subsequently aids in making informed health and lifestyle choices to mitigate disease risk. For example, in April 2023, the National Library of Medicine (NLM), a medical library based in the US, reported that approximately 6.7 million Americans aged 65 and above would be afflicted with Alzheimer’s dementia (AD) in 2023, a condition where genetics play a considerable part. This figure might increase to 13.8 million by 2060, assuming no significant medical advancements emerge to avert, delay, or treat AD. Consequently, the expanding prevalence of genetically transmissible diseases and disorders is fueling the demand for the direct-to-consumer (DTC) genetic testing market.
What Are The Major Segment Types Covered In The Direct-To-Consumer (DTC) Genetic Testing Market?
The direct-to-consumer (dtc) genetic testingmarket covered in this report is segmented –
1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types
2) By Sample: Saliva; Urine; Blood
3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis
4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode
5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User
Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders; X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions; Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis; DNA Matching For Relationships
4) By Nutrigenomic Testing: Dietary Recommendations; Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing; Health Trait Testing
What Key Innovation Trends Are Fueling Advancements In The Direct-To-Consumer (DTC) Genetic Testing Market?
Leading companies in the direct-to-consumer (DTC) genetic testing market are concentrating on funneling capital into genetic research to maintain their market presence. Financial injections provide the crucial support for genetic testing firms to conduct studies, refine technologies, extend their market footprint, ensure regulatory adherence, and propel innovation. As an illustration, in November 2022, Redcliffe Labs, an Indian provider of diagnostic centers and labs, unveiled its strategy to commit an additional $10 million (approximately Rs 81 crore) towards expanding its genetic and specialized testing offerings. This capital infusion aims to further advance the company’s genetic testing capabilities, covering domains such as prenatal diagnostics, oncology, neurology, nephrology, and pharmacogenomics. The company has previously invested $6 million in genetics and specialized testing coverage and is currently prioritizing next-generation technologies within the diagnostics industry.
Which Key Players Are Driving Competition In The Direct-To-Consumer (DTC) Genetic Testing Market?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Direct-To-Consumer (DTC) Genetic Testing Market During The Forecast Period?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Direct-To-Consumer (DTC) Genetic Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8957&type=smp
Browse Through More Reports Similar to the Global Direct-To-Consumer (DTC) Genetic Testing Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model